ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
RPG Life Sciences Ltd reported revenue from operations of ₹195.7 Cr (+15.9% YoY) and net profit of ₹30.8 Cr (+17.1% YoY) for Q1 FY27.
RPG Life Sciences Limited reported its FY26 results, with annual standalone total income of ₹733.06 Crore and net profit of ₹115.17 Crore. The Board recommended a dividend of ₹24 per share (300%). Additionally, Dr. Pratit Samdani was appointed as an Additional Independent Director for a five-year term.
RPG Life Sciences Ltd reported revenue from operations of ₹176.9 Cr (+23.6% YoY) and net profit of ₹29.9 Cr (-74.5% YoY) for Q4 FY26.
RPG Life Sciences Limited reported a standalone total income of ₹733.06 Crore for the year ended March 31, 2026. The Board recommended a dividend of ₹24 (300%) per equity share and appointed Dr. Pratit Samdani as an Additional Non-Executive Independent Director for five years.
RPG Life Sciences Ltd reported net profit of ₹22.1 Cr (-36.7% YoY) for Q3 FY26.